Search - tctmd.com

Displaying 21 - 40 of 40

Sort: Relevancy | Date

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis

L.A. McKeown

December 20, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Daily News

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

L.A. McKeown

September 25, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

News Conference News ESC 2017

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

Todd Neale

September 01, 2017

News Conference News ESC 2017

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

Todd Neale

August 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Michael O'Riordan

September 30, 2016

News Daily News

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

L.A. McKeown

August 17, 2016

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

CME

Aspirin for the Interventionalist: More Than Meets the Eye

CME

Advertisement

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Platelet Reactivity High in Most Patients Who Develop Stent Thrombosis

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies

New Performance and Quality Metrics for STEMI and NSTEMI Care

ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

TCTMD’s Top 10 Most Popular Stories for May 2017

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Aspirin for the Interventionalist: More Than Meets the Eye

Everyday Antiplatelet Decisions: Making the Right Choices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content